Feline enteric coronavirus (FECV) is the benign intestinal biotype of feline coronavirus that causes mild or subclinical gastrointestinal infection in cats worldwide. This common viral infection represents the typical presentation of feline coronavirus in the vast majority of infected cats, producing little to no clinical disease while the virus replicates in the cells lining the small intestine. FECV is extraordinarily prevalent in cat populations, with infection rates reaching eighty to ninety percent in multi-cat environments such as shelters and catteries, while even twenty-five to forty percent of cats in single-cat households test positive for exposure.
The virus spreads efficiently through the fecal-oral route, with cats becoming infected when they ingest viral particles shed in the feces of infected cats. Shared litter boxes serve as the primary transmission source, as cats may ingest virus during grooming of their paws after litter box use. The virus demonstrates considerable environmental stability, surviving for up to seven weeks under dry conditions, which contributes to its widespread prevalence. Kittens typically acquire infection between five and twelve weeks of age as protective maternal antibodies decline, often from chronic shedding by the queen or other adult cats in the environment.
The clinical significance of FECV infection lies primarily in its role as the precursor to feline infectious peritonitis (FIP), rather than in the intestinal disease it causes directly. In its enteric form, FECV rarely causes more than transient mild diarrhea, and many infected cats show no symptoms at all. However, within individual cats, FECV can undergo genetic mutations that transform it into the highly pathogenic FIP virus (FIPV). This mutation occurs in approximately five to twelve percent of infected cats, leading to the fatal systemic disease FIP. The factors determining which cats will experience this mutation are not fully understood, though stress, overcrowding, and possibly genetic factors play roles.
Management of FECV infection focuses on supportive care for the rare cat with significant symptoms and environmental management to reduce viral load and transmission in multi-cat settings. No specific antiviral treatment exists for FECV, and vaccination against feline coronavirus has shown limited efficacy. For most cat owners, awareness of FECV's existence and its relationship to FIP is more important than treating the enteric infection itself. Veterinary guidance is valuable for multi-cat households and catteries seeking to reduce coronavirus prevalence and for monitoring cats for any signs suggesting possible FIP development. The vast majority of FECV-infected cats live normal, healthy lives without any impact from their infection.
